![](https://investorshub.advfn.com/uicon/200692.png?cb=1486982540)
Tuesday, October 23, 2018 12:29:13 PM
Breaking a string of 57 straight losing quarters will take sales, and Keith's focus ought to be entirely on having deals ready and in place if/when full FDA clearance is provided. Operations will need to be ready and able to supply product, among a myriad of other critical items. Placing that on top of Keith's current duties is not a good idea - and it wouldn't do a thing to help the PPS, IMO. The PPS would benefit more by teaching Andy how to properly pronounce 'opioid' than it would by slamming Keith with COO duties.
The amount of work is just for starters - doesn't even begin to address the issue as to whether Keith is cut out for a COO role (not many marketing/sales personnel are - yes, a generalization, but a fair one).
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM